Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Saunders

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Respiratory Research|March 29, 2020
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitorToby M Maher, Juliet K Simpson, Joanna C Porter, et al.
BMJ Open Respiratory Research|September 15, 2020
Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experienceRob J Hallifax, Benedict Ml Porter, Patrick Jd Elder, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2019
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary FibrosisCamille Moore, Rachel Z Blumhagen, Ivana V Yang, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Respiratory Research|March 29, 2020
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitorToby M Maher, Juliet K Simpson, Joanna C Porter, et al.
BMJ Open Respiratory Research|September 15, 2020
Successful awake proning is associated with improved clinical outcomes in patients with COVID-19: single-centre high-dependency unit experienceRob J Hallifax, Benedict Ml Porter, Patrick Jd Elder, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|April 30, 2019
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary FibrosisCamille Moore, Rachel Z Blumhagen, Ivana V Yang, et al.
Pageof 4